Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 129
Filter
1.
Nat Rev Urol ; 17(8): 439-458, 2020 08.
Article in English | MEDLINE | ID: mdl-32661333

ABSTRACT

The bladder is continuously protected by passive defences such as a mucus layer, antimicrobial peptides and secretory immunoglobulins; however, these defences are occasionally overcome by invading bacteria that can induce a strong host inflammatory response in the bladder. The urothelium and resident immune cells produce additional defence molecules, cytokines and chemokines, which recruit inflammatory cells to the infected tissue. Resident and recruited immune cells act together to eradicate bacteria from the bladder and to develop lasting immune memory against infection. However, urinary tract infection (UTI) is commonly recurrent, suggesting that the induction of a memory response in the bladder is inadequate to prevent reinfection. Additionally, infection seems to induce long-lasting changes in the urothelium, which can render the tissue more susceptible to future infection. The innate immune response is well-studied in the field of UTI, but considerably less is known about how adaptive immunity develops and how repair mechanisms restore bladder homeostasis following infection. Furthermore, data demonstrate that sex-based differences in immunity affect resolution and infection can lead to tissue remodelling in the bladder following resolution of UTI. To combat the rise in antimicrobial resistance, innovative therapeutic approaches to bladder infection are currently in development. Improving our understanding of how the bladder responds to infection will support the development of improved treatments for UTI, particularly for those at risk of recurrent infection.


Subject(s)
Urinary Bladder Diseases/immunology , Urinary Bladder Diseases/microbiology , Urinary Bladder/immunology , Urinary Tract Infections/immunology , Humans
2.
BMJ Case Rep ; 20182018 Oct 24.
Article in English | MEDLINE | ID: mdl-30361450

ABSTRACT

Acute bacterial meningitis is not an uncommon central nervous system infection. In severe cases, it can be associated with various neurological or systemic complications. However, acute spinal cord dysfunction rarely occurs. We report a case of bacterial meningitis complicated with spinal cord infarction despite adequate treatment with antibiotics and corticosteroid therapy. He had residual paraplegia and was fully dependent in the activity of daily living.


Subject(s)
Central Nervous System Bacterial Infections/diagnosis , Meningitis, Bacterial/diagnosis , Spinal Cord Ischemia/microbiology , Spinal Cord/blood supply , Acute Disease , Adult , Central Nervous System Bacterial Infections/drug therapy , Humans , Infarction/microbiology , Male , Meningitis, Bacterial/drug therapy , Paraplegia/microbiology , Syndrome , Treatment Outcome , Urinary Bladder Diseases/microbiology
3.
Rev Chilena Infectol ; 34(2): 186-189, 2017 Apr.
Article in Spanish | MEDLINE | ID: mdl-28632834

ABSTRACT

Vesical fungus ball is a mobile, oval and echogenic mass as a result of accumulation of long and wide numerous hyphae. Fungal urinary tract infection incidence has increased notoriously and there are isolated yeast in 7 to 8% of urine cultures. Different species of Candida are cause of urinary tract infection. Epidemiologically, the first isolated pathogen is Candida albicans, followed by Candida tropicalis. Bladder poll has been documented as the most important risk factor for candiduria in critical patients into intensive care.


Subject(s)
Candida tropicalis/isolation & purification , Candidiasis/microbiology , Cross Infection/microbiology , Urinary Bladder Diseases/microbiology , Child, Preschool , Humans , Male
4.
Phytomedicine ; 28: 1-9, 2017 May 15.
Article in English | MEDLINE | ID: mdl-28478807

ABSTRACT

BACKGROUND: Extracts from the leaves of Orthosiphon stamineus are used in phytotherapy for treatment of uncomplicated urinary tract infections. PURPOSES: Evaluation of an aqueous extract against infection with uropathogenic Escherichia coli in vivo; investigation of underlying microbiological mechanisms. STUDY DESIGN: In vivo studies in mice and in vitro investigations on cytotoxicity, antiadhesive potential, influence on bacterial gene expression and quorum sensing. METHODS: Extract OWE was prepared by hot water extraction. For in vivo studies BALB/c mice were used in an UPEC infection model. The effect of OWE on bacterial load in bladder/kidney tissue was monitored in pre- and posttreatment. Cytotoxicity of OWE against different UPEC strains, T24 bladder/A498 kidney cells, gene expression analysis, monitoring of phenotypic motility and quorum sensing was investigated by standard methods of microbiology. RESULTS: OWE was quantified (UHPLC) according to the content of rosmarinic acid, cichoric acid, caffeic acid. Three- and 5-day treatment of animals with OWE (750mg/kg) after transurethral infection with UPEC CFT073 reduced the bacterial load in bladder and kidney, similar to norfloxacin. Four- and 7-day pretreatment of mice prior to the infection with UPEC NU14 reduced bacterial bladder colonization. In vitro investigations indicated that OWE (≤2mg/ml) has no cytotoxic or proliferation-inhibiting activity against different UPEC strains as well as against T24 bladder and A498 kidney cells. OWE exerts a dose dependent antiadhesive activity against UPEC strains NU14 and UTI89. OWE reduced gene expression of fimH, but evoked increase of the expression of motility/fitness gene fliC. Increase of bacterial motility on gene level was confirmed by a changed bacterial phenotype by an increased bacterial motility in soft agar assay. OWE inhibited in a concentration-dependent manner bacterial quorum sensing. CONCLUSION: OWE is assessed as a strong antiadhesive plant extract for which the traditional use in phytotherapy for UTI might be justified.


Subject(s)
Escherichia coli Infections/prevention & control , Kidney Diseases/prevention & control , Orthosiphon/chemistry , Plant Extracts/pharmacology , Urinary Bladder Diseases/prevention & control , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Disease Models, Animal , Epithelial Cells/drug effects , Escherichia coli Infections/drug therapy , Female , Humans , Kidney Diseases/microbiology , Kidney Diseases/pathology , Mice , Mice, Inbred BALB C , Plant Extracts/chemistry , Plant Leaves/chemistry , Urinary Bladder Diseases/microbiology , Urinary Tract Infections/microbiology , Uropathogenic Escherichia coli/drug effects , Uropathogenic Escherichia coli/pathogenicity
5.
Rev. chil. infectol ; 34(2): 186-189, abr. 2017. ilus
Article in Spanish | LILACS | ID: biblio-844462

ABSTRACT

Vesical fungus ball is a mobile, oval and echogenic mass as a result of accumulation of long and wide numerous hyphae. Fungal urinary tract infection incidence has increased notoriously and there are isolated yeast in 7 to 8% of urine cultures. Different species of Candida are cause of urinary tract infection. Epidemiologically, the first isolated pathogen is Candida albicans, followed by Candida tropicalis. Bladder poll has been documented as the most important risk factor for candiduria in critical patients into intensive care.


Un fungoma vesical es una masa móvil, oval y ecogénica en la vejiga resultante del acúmulo de hifas largas y anchas. La incidencia de la infección urinaria de etiología fúngica se ha incrementado notablemente. Se aíslan levaduras en 7 a 8% de los urocultivos. Diferentes especies de Candida son causantes de infección urinaria, siendo Candida albicans la más frecuente, seguida de Candida tropicalis. Presentamos el caso de un niño varón de cuatro años, con un síndrome de Guillain Barré, catéter urinario permanente, estadía prolongada en UCI y expuesto a tratamiento antibacteriano de amplio espectro que desarrolló un fungoma vesical, diagnosticado por ecotomografía, con aislamiento de C. tropicalis en orina. Se trató con anfotericina B deoxicolato y extracción del fungoma por cistoscopia, con buena respuesta clínica. El cateterismo vesical se ha documentado como el factor de riesgo más importante para candiduria en pacientes de terapia intensiva.


Subject(s)
Humans , Male , Child, Preschool , Urinary Bladder Diseases/microbiology , Candidiasis/microbiology , Cross Infection/microbiology , Candida tropicalis/isolation & purification
7.
Curr Opin Urol ; 27(3): 282-286, 2017 May.
Article in English | MEDLINE | ID: mdl-28234750

ABSTRACT

PURPOSE OF REVIEW: The newly discovered female urinary microbiota has the potential to deepen our understanding of urinary tract health and disease, including common lower urinary tract conditions such as urinary incontinence and urinary tract infection. The spectrum of painful bladder disorders and other less common conditions also may benefit from additional research that includes consideration of the resident bacterial community of the female bladder. The present review provides a clinical context for the rapidly emerging research regarding the female urinary microbiota and its relationships with urinary tract conditions of interest. RECENT FINDINGS: Studies using culture-independent techniques confirm prior reports of bacteria that reside in the female urinary bladder. These resident communities, the female urinary microbiota, possess characteristics that differ between women affected by urgency urinary incontinence and matched, unaffected controls. Enhanced urine culture techniques permit cultivation of organisms, including uropathogens, missed by standard urine culture, but detected by culture-independent sequencing techniques. SUMMARY: New technology is available. Clinical laboratories can modify traditional standard urine culture methods to enhance detection of uropathogens. However, given the existence of the female urinary microbiota, the simple presence of bacteria in the lower urinary tract should not be taken as evidence of infection.


Subject(s)
Microbiota , Urinary Bladder Diseases/microbiology , Urinary Incontinence/microbiology , Urinary Tract Infections/microbiology , Female , Humans , Urinalysis , Urinary Bladder/microbiology , Urinary Incontinence/physiopathology
9.
Article in English | MEDLINE | ID: mdl-27512653

ABSTRACT

OBJECTIVES: Traditionally, the urinary tract has been thought to be sterile in the absence of a clinically identifiable infection. However, recent evidence suggests that the urinary tract harbors a variety of bacterial species, known collectively as the urinary microbiome, even when clinical cultures are negative. Whether these bacteria promote urinary health or contribute to urinary tract disease remains unknown. Emerging evidence indicates that a shift in the urinary microbiome may play an important role in urgency urinary incontinence (UUI). The goal of this prospective pilot study was to determine how the urinary microbiome is different between women with and without UUI. We also sought to identify if characteristics of the urinary microbiome are associated with UUI severity. METHODS: We collected urine from clinically well-characterized women with UUI (n = 10) and normal bladder function (n = 10) using a transurethral catheter to avoid bacterial contamination from external tissue. To characterize the resident microbial community, we amplified the bacterial 16S rRNA gene by PCR and performed sequencing using Illumina MiSeq. Sequences were processed using the workflow package QIIME. We identified bacteria that had differential relative abundance between UUI and controls using DESeq2 to fit generalized linear models based on the negative binomial distribution. We also identified relationships between the diversity of the urinary microbiome and severity of UUI symptoms with Pearson's correlation coefficient. RESULTS: We successfully extracted and sequenced bacterial DNA from 95% of the urine samples and identified that there is a polymicrobial community in the female bladder in both healthy controls and women with UUI. We found the relative abundance of 14 bacteria significantly differed between control and UUI samples. Furthermore, we established that an increase in UUI symptom severity is associated with a decrease in microbial diversity in women with UUI. CONCLUSIONS: Our study provides further characterization of the urinary microbiome in both healthy controls and extensively phenotyped women with UUI. Our results also suggest that the urinary microbiome may play an important role in the pathophysiology of UUI and that the loss of microbial diversity may be associated with clinical severity.


Subject(s)
Bacteria/isolation & purification , Microbiota/physiology , Urinary Incontinence/microbiology , Adult , Aged , Bacteria/classification , Bacteria/genetics , Base Sequence , Biodiversity , Case-Control Studies , DNA, Bacterial/genetics , Female , Humans , Microbiota/genetics , Middle Aged , Phylogeny , Pilot Projects , Prospective Studies , Severity of Illness Index , Urinary Bladder Diseases/microbiology , Urinary Bladder Diseases/urine , Urinary Incontinence/physiopathology , Urinary Incontinence/urine , Urinary Tract/microbiology
10.
Kansenshogaku Zasshi ; 90(6): 809-13, 2016 Nov.
Article in Japanese | MEDLINE | ID: mdl-30277373

ABSTRACT

We report a case of iatrogenic vesical tuberculosis diagnosed 4 years after intravesical immunotherapy using Bacillus Calmette- Guérin (BCG) for the treatment of bladder carcinoma. A 72-year-old man underwent a transurethral resection (TUR) of multiple noninvasive urothelial carcinomas and intravesical BCG infusion (40 mg/week) for 7 weeks to prevent the recurrence of bladder carcinoma. BCG infusion therapy was terminated because of the appearance of Reiter's syndrome, including arthritis of the left toe joint, conjunctivitis and non-gonococcal urethritis as complications. The patient suffered from repeated cystitis, bladder atrophy and urethral stenosis. The cystitis improved with the administration of antibiotics (Levofloxacin) but persisted without a complete cure. Four years later, a cystoscopy revealed mucosal erosion and a white coating. An acid-fast bacteria examination of a urine sample using bacteria incubation and DNA PCR revealed the presence of Mycobacterium bovis. Finally, anti-tuberculosis therapy (INH+REP+EB) was initiated after the patient was diagnosed as having iatrogenic bladder tuberculosis resulting from BCG immunotherapy. The tuberculosis bacteria subsequently disappeared from the urine samples, and the gross appearance of the bladder mucosa improved. Bladder carcinoma has not recurred to date. Intravesical BCG infusion therapy has a good anti-tumor effect and can help prevent tumor recurrence after TUR therapy in case of noninvasive bladder carcinoma. However, there is a risk of severe complications arising from the BCG infusion. In the present case, an adequate bacteria examination was not performed, even though antibiotics were repeatedly administered for cystitis. In particular, the patient was not tested for the presence of acid-fast bacteria for 4 years after the intravesical BCG infusion therapy. Furthermore, among patients who received anti-bacteria therapy for repeated cystitis after BCG infusion, a bacteria examination including bacteria incubation, was not ordered in 19 out of 30 cases treated at our hospital over the past 5 years. In conclusion, bacteria examination, including tests for acid-fast bacteria, should be immediately performed when repeated and/or persistent cystitis occurs after BCG infusion therapy.


Subject(s)
BCG Vaccine/adverse effects , Tuberculosis/etiology , Urinary Bladder Diseases/microbiology , Urinary Bladder Neoplasms/prevention & control , Administration, Intravesical , Aged , BCG Vaccine/administration & dosage , BCG Vaccine/therapeutic use , Humans , Iatrogenic Disease , Immunotherapy , Male , Recurrence , Secondary Prevention , Time Factors , Urinary Bladder Neoplasms/immunology
11.
Urologiia ; (3): 29-32, 2015.
Article in Russian | MEDLINE | ID: mdl-26390556

ABSTRACT

UNLABELLED: The fourth, terminal, stage of bladder tuberculosis (BT) manifests itself in irreversible changes and requires surgical treatment. OBJECTIVE: To identify the reasons for delayed diagnosis of this urogenital tuberculosis complication. Medical history of 26 urogenital tuberculosis patients with a complicated form of stage 4 BT, referred to the Novosibirsk TB Research Institute for reconstructive surgery were analysed. In 22 patients, bladder volume ranged from 55 to 100 ml, 4 patients previously underwent cystostomy due to extremely small bladder volume. Average duration of BT hidden in the guise of "urogenital infection" was 6.2 years. Patients were treated with norfloxacin (a total of 104 courses), ciprofloxacin (86 courses), amikacin (43 courses), nitroxoline (27 courses), third generation cephalosporins (32 courses), lomefloxacin (17 courses), levofloxacin (11 courses), Amoxicillin clavulanate (4 courses), ampicillin (2 courses). It was demonstrated that all cases of BT stage 4 were iatrogenic. Irreversible debilitating complications occurred due to suboptimal therapy, primarily due to administration of amikacin and fluoroquinolones for urogenital infections, which was tuberculosis in disguise. Absence of M. tuberculosis growth does not exclude tuberculosis; pathological specimens must be further examined at least by PCR. Interventional material must be mandatory examined histologically and stained by Ziehl-Neelsen method to identify M. tuberculosis. Effective and not masking tuberculosis, optimal therapy for urogenital infections includes fosfomycin, furazidin (nitrofurantoin), gentamicin, III generation cephalosporins (in outpatient settings dispersible form of efixime should be preferable).


Subject(s)
Delayed Diagnosis , Tuberculosis, Urogenital/microbiology , Urinary Bladder Diseases/microbiology , Antitubercular Agents/administration & dosage , Antitubercular Agents/therapeutic use , Cystitis/microbiology , Diagnosis, Differential , Female , Humans , Iatrogenic Disease , Male , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Severity of Illness Index , Tuberculosis, Urogenital/drug therapy , Tuberculosis, Urogenital/pathology , Tuberculosis, Urogenital/surgery , Urinary Bladder Diseases/drug therapy , Urinary Bladder Diseases/pathology , Urinary Bladder Diseases/surgery
13.
Proc Natl Acad Sci U S A ; 110(47): 19089-94, 2013 Nov 19.
Article in English | MEDLINE | ID: mdl-24191044

ABSTRACT

Inhibiting antibodies targeting receptor-binding pockets in proteins is a major focus in the development of vaccines and in antibody-based therapeutic strategies. Here, by using a common mannose-specific fimbrial adhesin of Escherichia coli, FimH, we demonstrate that locking the adhesin in a low-binding conformation induces the production of binding pocket-specific, adhesion-inhibiting antibodies. A di-sulfide bridge was introduced into the conformationally dynamic FimH lectin domain, away from the mannose-binding pocket but rendering it defective with regard to mannose binding. Unlike the native, functionally active lectin domain, the functionally defective domain was potent in inducing inhibitory monoclonal antibodies that blocked FimH-mediated bacterial adhesion to epithelial cells and urinary bladder infection in mice. Inhibition of adhesion involved direct competition between the antibodies and mannose for the binding pocket. Binding pocket-specific inhibitory antibodies also were abundant in polyclonal immune serum raised against the functionally defective lectin domain. The monoclonal antibodies elicited against the binding-defective protein bound to the high-affinity conformation of the adhesin more avidly than to the low-affinity form. However, both soluble mannose and blood plasma more strongly inhibited antibody recognition of the high-affinity FimH conformation than the low-affinity form. We propose that in the functionally active conformation the binding-pocket epitopes are shielded from targeted antibody development by ligand masking and that strong immunogenicity of the binding pocket is unblocked when the adhesive domain is in the nonbinding conformation.


Subject(s)
Adhesins, Escherichia coli/chemistry , Antibodies, Monoclonal/immunology , Binding Sites, Antibody/immunology , Escherichia coli/metabolism , Fimbriae Proteins/chemistry , Models, Molecular , Protein Conformation , Urinary Bladder Diseases/microbiology , Adhesins, Escherichia coli/genetics , Animals , Bacterial Adhesion/immunology , Escherichia coli/genetics , Fimbriae Proteins/genetics , Mannose/metabolism , Mice , Mutation, Missense/genetics , Protein Binding , Urinary Bladder Diseases/immunology
19.
Nature ; 472(7341): 110-4, 2011 Apr 07.
Article in English | MEDLINE | ID: mdl-21389986

ABSTRACT

Epithelial integrity in metazoan organs is maintained through the regulated proliferation and differentiation of organ-specific stem and progenitor cells. Although the epithelia of organs such as the intestine regenerate constantly and thus remain continuously proliferative, other organs, such as the mammalian urinary bladder, shift from near-quiescence to a highly proliferative state in response to epithelial injury. The cellular and molecular mechanisms underlying this injury-induced mode of regenerative response are poorly defined. Here we show in mice that the proliferative response to bacterial infection or chemical injury within the bladder is regulated by signal feedback between basal cells of the urothelium and the stromal cells that underlie them. We demonstrate that these basal cells include stem cells capable of regenerating all cell types within the urothelium, and are marked by expression of the secreted protein signal Sonic hedgehog (Shh). On injury, Shh expression in these basal cells increases and elicits increased stromal expression of Wnt protein signals, which in turn stimulate the proliferation of both urothelial and stromal cells. The heightened activity of this signal feedback circuit and the associated increase in cell proliferation appear to be required for restoration of urothelial function and, in the case of bacterial injury, may help clear and prevent further spread of infection. Our findings provide a conceptual framework for injury-induced epithelial regeneration in endodermal organs, and may provide a basis for understanding the roles of signalling pathways in cancer growth and metastasis.


Subject(s)
Epithelial Cells/cytology , Hedgehog Proteins/metabolism , Regeneration/physiology , Stem Cells/cytology , Urinary Bladder/cytology , Wnt Proteins/metabolism , Animals , Cell Lineage , Cell Proliferation , Epithelial Cells/metabolism , Feedback, Physiological , Female , Fibroblast Growth Factors/metabolism , Kruppel-Like Transcription Factors/genetics , Kruppel-Like Transcription Factors/metabolism , Mice , Organoids/cytology , Signal Transduction , Stem Cells/metabolism , Stromal Cells/cytology , Stromal Cells/metabolism , Urinary Bladder/drug effects , Urinary Bladder/injuries , Urinary Bladder/metabolism , Urinary Bladder Diseases/chemically induced , Urinary Bladder Diseases/metabolism , Urinary Bladder Diseases/microbiology , Urinary Bladder Diseases/pathology , Uropathogenic Escherichia coli/physiology , Urothelium/cytology , Zinc Finger Protein GLI1
20.
Int Urol Nephrol ; 43(2): 423-30, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20680448

ABSTRACT

OBJECTIVE: To document the management of tuberculous cicatrized urinary bladder by incorporating bowel segment and the long-term follow-up after the reconstructive surgery. MATERIALS AND METHODS: Twenty-three patients (out of 28) were managed by augmentation cystoplasty (AC) and 5 by orthotopic neobladder (OTN) reconstruction. Sigmoidocystoplasty was performed in 11 cases, ileocystoplasty in 10 patients and ileocecocystoplasty in 2 patients. Ileal neobladder reconstruction was done in 2 patients, ileocecal neobladder reconstruction in 1 patient and sigmoid neobladder reconstruction in 2 patients, respectively. The patients were followed according to standard follow-up protocols. RESULT: The mean age of patients who underwent AC was 32.5 years and of those who underwent OTN reconstruction was 31 years. The mean pre-operative bladder capacity in patients with AC was 70 ml (range 40-100 ml) and of patients with OTN reconstruction was 14 ml (range 10-20 ml). The mean postoperative bladder capacity at 3 months following AC was 427 ml (range 450-500 ml) and following OTN reconstruction it was 430 ml (range 350-450 ml). The mean follow-up in patients who underwent AC was 43.3 months (range 12-90 months) and in those who underwent OTN reconstruction it was 35.6 months (16-60 months). None of the patients had upper urinary tract deterioration following the reconstructive surgery. CONCLUSION: Urinary bladder rehabilitation either by AC or OTN reconstruction increases the bladder capacity and storage time and also preserves the upper tracts.


Subject(s)
Tuberculosis, Urogenital/surgery , Urinary Bladder Diseases/microbiology , Urinary Bladder Diseases/surgery , Adult , Cicatrix/etiology , Cicatrix/surgery , Female , Humans , India , Male , Middle Aged , Retrospective Studies , Tuberculosis, Urogenital/complications , Urinary Bladder Diseases/complications , Urologic Surgical Procedures/methods , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...